tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Scott Henry, 85 are a BUY (85.86%), 14 are a HOLD (14.14%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 54.12% that have a potential upside of 42.61% achieved within 160 days. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 187 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 19-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$94
$26.48 (39.22%)
$94
19 days ago
(17-Mar-2025)
4/13 (30.77%)
$29.65 (46.08%)
148
Buy
$86
$18.48 (27.37%)
$77
1 months ago
(05-Mar-2025)
3/8 (37.5%)
$26.32 (44.10%)
89
Hold
$62
$-5.52 (-8.18%)
$60
5 months 14 days ago
(22-Oct-2024)
4/9 (44.44%)
$1.92 (3.20%)
52
Buy
$83
$15.48 (22.93%)
$49
6 months 18 days ago
(18-Sep-2024)
10/12 (83.33%)
$21.95 (35.95%)
474
Hold
$42
$-25.52 (-37.80%)
$40
1 years 10 months 28 days ago
(08-May-2023)
2/3 (66.67%)
$-0.58 (-1.36%)
274
Which stock is Scott Henry is most bullish on?
What Year was the first public recommendation made by Scott Henry?
